Please use this identifier to cite or link to this item:
|Title:||Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009||Authors:||Lee, V.J.
|Issue Date:||10-Jun-2010||Citation:||Lee, V.J., Yap, J., Tay, J.K., Barr, I., Gao, Q., Ho, H.J., Tan, B.H., Kelly, P.M., Tambyah, P.A., Kelso, A., Chen, M.I. (2010-06-10). Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. BMC Infectious Diseases 10 : -. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2334-10-164||Abstract:||Background: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis.Methods: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered. The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week. Three blood samples were taken for haemagglutination inhibition testing - at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore. Questionnaires were also administered to collect clinical symptoms.Results: 237 personnel were included for analysis. The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237). This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis. Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR. Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted. There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888). No allergic, neuropsychiatric or other severe side-effects were noted.Conclusions: Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation. Asymptomatic infections occur during prophylaxis, which may confer protection against future infection. Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks. © 2010 Lee et al; licensee BioMed Central Ltd.||Source Title:||BMC Infectious Diseases||URI:||http://scholarbank.nus.edu.sg/handle/10635/109647||ISSN:||14712334||DOI:||10.1186/1471-2334-10-164|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
|2010-Seroconversion_asymptomatic_infections_during_oseltamivir-published.pdf||457.13 kB||Adobe PDF|
checked on May 5, 2021
WEB OF SCIENCETM
checked on Apr 28, 2021
checked on May 2, 2021
checked on May 2, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.